Search Results
151 items found for "Systemic treatment"
- Ep 124 with Gáspár Pándy-Szekeres
have branched out to multiple areas of GPCR research such as sequence alignments, generic numbering systems
- Ep 138 with Dr. Daniel Isom
of Medicine in 2016, where he is currently a practicing molecular pharmacologist and biophysicist, systems
- Ep 123 with Dr. Lukas Grätz
have branched out to multiple areas of GPCR research such as sequence alignments, generic numbering systems
- CircFKBP5 Suppresses Apoptosis and Inflammation and Promotes Osteogenic Differentiation
Besides, GIT2 expression was decreased in hDPSCs after LPS treatment. experiments showed that GIT2 could mediate the protective functions of circFKBP5 on hDPSCs under LPS treatment
- The combination of brentuximab vedotin and chidamide synergistically suppresses the proliferation of T-cell lymphoma cells through the enhancement of apoptosis
an anti-CD30 monoclonal antibody linked to a microtubule-disrupting agent, has been approved for the treatment chidamide and BV were demonstrated in a study of HH-cell xenograft mice; mean tumor size following combined treatment
- Wnt pathway inhibition with the porcupine inhibitor LGK974 decreases trabecular bone but not fibrosis in a murine model with fibrotic bone
Treatment with the porcupine inhibitor LGK974, which blocks Wnt signaling broadly, induced partial resorption Bone fibrosis remained evident after treatment.
- Clinical, pathophysiologic, genetic and therapeutic progress in Primary Bilateral Macronodular Adrenal Hyperplasia
Treatment is reserved for patients with overt or mild cortisol/aldosterone or other steroid excesses adrenalectomy; however recent studies tend to favor unilateral adrenalectomy, or less frequently, medical treatment
- Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas/somatotroph pituitary neuroendocrine tumors
and WWC3, SERINC1, and ZFAND3 correlated with the tumor volume change rate after somatostatin analog treatment characteristics of acromegaly, revealing molecules associated with acromegaly that may affect medical treatment
- Comparative Analysis of the GNAI Family Genes in Glioblastoma through Transcriptomics and Single-Cell Technologies
The treatment of GBM is challenging due to the presence of the blood-brain barrier (BBB), which hinders Hence, identifying the crucial pathways and biomarkers for the treatment of GBM is of prime importance
- Ep 52 with Dr. Benjamin Myers
with David Julius on the structure, function, and physiology of ion channels and GPCRs in the nervous system
- Ep 38 with Dr. Alexander S. Hauser
Design and Pharmacology in Copenhagen, he worked on novel analytical methods to identify human signaling systems
- Abstract Submission Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Signaling Trafficking Metabolism Structure and Bioinformatics Health and Disease Immunology Nervous system
- Ep 85 with Nicholas Holliday
work that led to Nick's interest in peptide messengers regulating appetite, metabolism, and the immune system
- Ep 34 with Dr. Brian Arey
molecular, biochemical, cellular, and in vivo assessment of drug candidates in many different physiological systems
- Ep 35 with Dr. Brian Arey
molecular, biochemical, cellular, and in vivo assessment of drug candidates in many different physiological systems
- Ep 73 with Dr. Aylin Hanyaloglu
crosstalk, and applying these mechanisms for distinct GPCRs in diverse physiological and pathophysiological systems
- Full Agenda for Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
Welcoming Remarks Read More 10:00 AM Student Flash Presentations Health and Disease, Metabolism, Nervous System Laurent Sabbagh · Ana Lilia Moreno Salinas Read More 12:00 PM Session IV AGPCRs signaling in the nervous system PM Complimentary Reception dinner Read More Oct 25 - 9:00 AM Session VI AGPCRs shaping the nervous system snacks Read More 10:30 AM Session VII Physiological and pathological roles of AGPCRs in the nervous system
- Ep 37 with Dr. Samuel Hoare
science, and academic scientists in the development of new therapeutics and the understanding of receptor systems
- Ep 136 with Murat Tunaboylu & Ben Holland
Mid-career, he has worked in finance and developed high-frequency trading systems.
- Ep 126 with Dr. Françoise Bachelerie
activation/function of CXCR4-ACKR3 (CXCR7) receptors of the CXCL12 chemokine, key effectors of the immune system
- Retreat | Dr. GPCR Ecosystem
will grant you access to a wealth of resources, research, and discussions on your favorite receptor system
- Ep 79 with Dr. Graeme Milligan
steatohepatitis (NASH) and inflammatory diseases and Keltic Pharma Therapeutics (2020) which is developing new treatments
- G Proteins and GPCRs in Cancer: Novel Precision Targeted and Immunotherapies
signaling circuitries and individual genomic and molecular alterations to develop new precision cancer treatments
- Ep 64 with Dylan Eiger
He hopes to continue his research on biased agonism at GPCRs with a particular focus on the treatment
- Ep 18 with Dr. Yamina Berchiche
This comes without the need for manual feature engineering as systems can learn through implicit rules
- Ep 65 with Dr. Sudarshan Rajagopal
The chemokine system is relatively unique in having multiple receptors and multiple ligands that display
- Chemokine Physiology in Cancer
Chemokines are a physiologic system that is finely tuned by ligand and receptor expression, ligand or
- Ep 143 with Dr Davide Calebiro
Molecular Endocrinology and Wellcome Trust Senior Research Fellow at the Institute of Metabolism and Systems